Immunosuppressed patients diagnosed with non-melanoma skin cancer are not lacking vital cancer-fighting immune cells as previously believed, but rather possess macrophages that have lost their ability to communicate effectively, according to a study published in Cell by researchers at The University of Texas MD Anderson Cancer Center. The findings reveal that macrophages in patients with weakened immune systems were less effective at sending cancer-related signals to other cells, a discovery that could reshape therapeutic approaches for aggressive skin malignancies.
Why Non-Melanoma Skin Cancer Becomes Dangerous for Immunosuppressed Patients
Non-melanoma skin cancer is the most common cancer in the U.S. Individuals with compromised immune systems—such as organ transplant recipients and those managing specific blood cancers—face a heightened risk of developing aggressive forms of the disease. Often, their immunosuppression excludes these patients from being treated with immune checkpoint inhibitors that benefit other patients, leaving them with no immunotherapy options.
Data analyzed from 138 patients in the study highlight the stark survival disparity. Patients with weakened immune systems experienced shorter disease-free survival periods and a five-year overall survival rate of 33%. By comparison, patients with normal immune function recorded a 5-year overall survival rate of 68.8%.
Did you know? Macrophages normally act as key coordinators in the body’s immune response. When functioning normally, these white blood cells help T cells recognize and actively attack cancer.
Cellular Communication Breakdown Identified Through Single-Cell Analysis
For years, the prevailing thought has been that immunosuppressed patients simply possessed fewer of these important immune cells. However, single-cell analysis performed by the MD Anderson team proved otherwise. Tumors taken from immunosuppressed patients contained many of the same immune-cell types, but these cells exhibited severe functional deficits.
According to Moran Amit, M.D., Ph.D., assistant professor of Head and Neck Surgery, the quality of immune cells and their interactions may be just as important as the number of cells present. The study revealed that macrophages in immunosuppressed patients displayed reduced receptor diversity, suggesting that their ability to recognize cancer cells was more limited and they were less effective at transmitting signals to other cells.
Shifting Treatment Approaches Based on Innate Immunity
The discovery changes how researchers approach skin cancer in vulnerable populations. Instead of focusing solely on restoring cell counts, future clinical strategies may concentrate on boosting innate immunity and repairing lost cell communication. Co-led by Kunal Rai, Ph.D., Frederico Gleber-Netto, D.D.S., Ph.D., Priyadharsini Nagarajan, M.D., Ph.D., and Michael Migden, M.D., the research team is actively investigating methods to help these immune cells recover their lost functionality.
Amit noted that knowing the cells are there changes how they approach this problem. Researchers are currently exploring techniques to prevent or reverse the cellular alterations that blunt immune responses, opening new therapeutic avenues for patients who lacked viable treatment options.
Frequently Asked Questions
What causes non-melanoma skin cancer to be more aggressive in transplant recipients?
According to MD Anderson researchers, immunosuppressed patients harbor macrophages with reduced receptor diversity and impaired signaling capabilities, preventing immune cells from effectively communicating to fight the tumor.
What was the survival rate difference found in the Cell study?
The study of 138 patients showed that immunosuppressed patients had a five-year overall survival rate of 33%, compared to 68.8% for patients with normal immune function.
How do macrophages normally help fight cancer?
Macrophages are white blood cells that coordinate the immune response by helping T cells recognize and attack cancer.
What are the next steps for this skin cancer research?
Researchers are investigating ways to boost innate immunity and help existing macrophages recover their lost functionality and communication pathways.
Join the Discussion: What are your thoughts on this breakthrough in cancer immunology? Share your questions or insights in the comments below, and subscribe to our newsletter for the latest updates in medical research.
Related reading